Serial analysis of gene expression and cancer.

Abstract:

:Serial analysis of gene expression has been widely used to characterize gene expression patterns associated with tumor formation. These studies resulted in the identification of tumor-specific markers, transcriptional pathways, or therapeutic targets. In this review, recent applications and developments of serial analysis of gene expression and their impact on the diagnosis and treatment of cancer are discussed. A combination of serial analysis of gene expression and small-scale microarray analysis represents a strategy that should facilitate the identification and exploitation of tumor-specific gene expression for diagnostic or therapeutic purposes. In addition, cancer diagnosis and treatment may benefit from a complementation between serial analysis of gene expression and quantitative proteomics in the future.

journal_name

Curr Opin Oncol

authors

Hermeking H

doi

10.1097/00001622-200301000-00006

keywords:

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

44-9

issue

1

eissn

1040-8746

issn

1531-703X

journal_volume

15

pub_type

杂志文章,评审
  • Approaches to relapse after allogeneic stem cell transplantation.

    abstract:PURPOSE OF REVIEW:Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328342c6c8

    authors: Kröger N

    更新日期:2011-03-01 00:00:00

  • Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects.

    abstract:PURPOSE OF REVIEW:Temsirolimus (Torisel) is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of relapsed/refractory mantle cell lymphoma (MCL). The recommended dosage in this indication (175 mg once weekly for 3 weeks and then 75 mg once weekly as maintenance) is higher than that for renal ce...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835de8ee

    authors: Bouabdallah K,Ribrag V,Terriou L,Soria JC,Delarue R

    更新日期:2013-03-01 00:00:00

  • Preclinical studies, experimental therapeutics, and clinical management of advanced melanoma.

    abstract::The preclinical and clinical investigations of therapeutic approaches to melanoma have progressed significantly in the past year. This article reviews recently published information relevant to preclinical studies of the biologic function of stromal tissue, growth factors (and receptors), interferons, cytokines, and a...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00020

    authors: Kirkwood JM

    更新日期:1992-04-01 00:00:00

  • Therapy-related myeloid neoplasms.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MN), taking into account the new 2008 WHO classification, new genome-wide approaches for the definition of susceptibility towards t-MN and the introduction of new more aggressive treatments in cancer patients. R...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32834bcc2a

    authors: Leone G,Fianchi L,Voso MT

    更新日期:2011-11-01 00:00:00

  • Recent advances in systemic therapy for breast cancer.

    abstract::During the past year there have been a number of important advances in the area of systemic therapy for breast cancer. Combined chemoendocrine therapy has been shown to be more effective than tamoxifen alone in the adjuvant therapy of node-negative estrogen receptor-positive breast cancer. Preliminary results of a ran...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199811000-00007

    authors: Dees EC,Kennedy MJ

    更新日期:1998-11-01 00:00:00

  • Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose?

    abstract:PURPOSE OF REVIEW:Gastrointestinal stromal tumour patients with exon 9 KIT mutations have a worse outcome, but progression-free survival is improved by treatment with imatinib 800 mg daily. This review looks at the evidence and asks whether this should be standard treatment from diagnosis. RECENT FINDINGS:The phase II...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328302ed96

    authors: Judson I

    更新日期:2008-07-01 00:00:00

  • Myelodysplastic syndromes in children.

    abstract:PURPOSE OF REVIEW:Myelodysplastic syndromes (MDSs) are rare disorders in children, showing peculiar clinical manifestations and biological features. This review will summarize biological, genetic and clinical features of childhood MDS and will provide an update of the algorithm of treatment of the different disease var...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000488

    authors: Galaverna F,Ruggeri A,Locatelli F

    更新日期:2018-11-01 00:00:00

  • Recent advances in breast cancer biology.

    abstract::Approximately 1 in 10 US women will be diagnosed with breast cancer in her lifetime. With such a high incidence, breast cancer is a serious health concern for all American women. Within the past year, clues about the function of genes associated with breast cancer have been garnered, and novel genes that may contribut...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200011000-00002

    authors: Unger MA,Weber BL

    更新日期:2000-11-01 00:00:00

  • Critical care management of cancer patients: cause for optimism and need for objectivity.

    abstract:PURPOSE OF REVIEW:In the 1990s, cancer patients were described as poor candidates for ICU admission on the basis of high mortality rates and management costs. Over the last decade, however, advances in the management of malignancies and organ failures have led to substantial increases in survival. This review discusses...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32832b68b6

    authors: Darmon M,Azoulay E

    更新日期:2009-07-01 00:00:00

  • The Ewing family of tumors and the search for the Achilles' heel.

    abstract::The ideal cancer therapy would accomodate the specific biology of a tumor and be based upon understanding the mechanisms of malignancy. This vision has been the driving force in cancer research. However, the story of success in clinical cancer management is a story of empirie largely independent from progress in basic...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199907000-00007

    authors: Kovar H,Aryee D,Zoubek A

    更新日期:1999-07-01 00:00:00

  • Targeting c-MET in the battle against advanced nonsmall-cell lung cancer.

    abstract:PURPOSE OF REVIEW:The mesenchymal-epidermal transition (c-MET) receptor tyrosine kinase has a central role in the cancer cell's survival. MET and its ligand, hepatocyte growth factor (HGF), have recently been identified as promising targets in solid tumors, including nonsmall-cell lung cancer (NSCLC). RECENT FINDINGS:...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835daf37

    authors: Landi L,Minuti G,D'Incecco A,Cappuzzo F

    更新日期:2013-03-01 00:00:00

  • Biologic therapy for lymphoma.

    abstract::Biologic approaches to lymphoma treatment are now a practical reality rather than a vaguely perceived hope for the future. Interferon alfa seems to have been established as a life-extending therapy for selected patients with follicular lymphoma. Humanized anti-CD20 monoclonal antibody (rituximab) has an authentic 50% ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199909000-00005

    authors: Bendandi M,Longo DL

    更新日期:1999-09-01 00:00:00

  • Can we define the optimal sequence of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of epidermal growth factor receptor-mutant nonsmall cell lung cancer?

    abstract:PURPOSE OF REVIEW:The most common mechanism of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is acquisition of the T790M gatekeeper mutation. Third-generation EGFR TKIs irreversibly inhibit EGFR mutants (EGFRm), especially T790M, while sparing wild-type EGFR. There are several ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000350

    authors: Sun JM,Park K

    更新日期:2017-03-01 00:00:00

  • Neurological paraneoplastic syndromes: an update.

    abstract:PURPOSE OF REVIEW:To describe recent advances in the diagnosis and treatment of paraneoplastic neurological syndromes (PNS). RECENT FINDINGS:PNS are rare complications of cancer caused by an immune cross-reaction between antigens expressed by tumor cells and neurons. The target of the immune attack can be an intracell...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000479

    authors: Berzero G,Psimaras D

    更新日期:2018-11-01 00:00:00

  • Surgical chores and approach in the management of endometrial cancer.

    abstract::Carcinoma of the uterine corpus is the most common malignancy in the female pelvis. Surgical resection and staging are now the accepted approach to therapy, with excellent survival compared with other gynecologic malignancies. Several controversies exist, however, regarding optimal surgical management. Some of these c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200209000-00007

    authors: McAlpine JN,Spirtos NM,Chen MD

    更新日期:2002-09-01 00:00:00

  • Hematopoietic stem cell transplantation for AIDS-related malignancies.

    abstract:PURPOSE OF REVIEW:AIDS-related malignancies are an ongoing cause of mortality in individuals with HIV infection. In the HIV-negative setting, high-dose chemotherapy or stem cell transplantation is an option for patients with hematologic malignancies. Prior to the advent of effective HIV therapy, stem cell transplantati...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833d2cf0

    authors: Krishnan A,Forman SJ

    更新日期:2010-09-01 00:00:00

  • Bevacizumab in the treatment of metastatic breast cancer: three case reports.

    abstract::Case reports are presented for three patients with metastatic breast cancer who received first-line treatment with bevacizumab in combination with taxanes in clinical trials. Two patients showed peak reductions in lesion size of 49 and 70%, respectively. In one patient, subsequent treatment with bevacizumab in combina...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/01.cco.0000397418.52374.28

    authors: Ferreira A,Vieira C,Rodrigues A,Pereira D,Rodrigues H,Dávila C,Bento S

    更新日期:2011-04-01 00:00:00

  • Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.

    abstract::The vast majority of adults with acute lymphoblastic leukemia (ALL) now achieve remission with current intensive chemotherapy regimens. Nevertheless, most adults with ALL will eventually relapse and die of their disease. Specific clinical and molecular-cytogenetic prognostic factors have been identified that are begin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200101000-00004

    authors: Verma A,Stock W

    更新日期:2001-01-01 00:00:00

  • Rectal cancer: state of the art in 2012.

    abstract:PURPOSE OF REVIEW:To discuss the recent developments of multimodal treatment for patients with local advanced rectal cancer, including incorporation of new chemotherapeutic and targeted agents, and the optimal sequence and timing of treatment components. RECENT FINDINGS:Five randomized trials have been completed to de...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328352ea02

    authors: Rödel C,Hofheinz R,Liersch T

    更新日期:2012-07-01 00:00:00

  • High dose cytarabine or transplantation for consolidation of younger patients with acute myeloid leukemia.

    abstract::Collaborative study groups have invested considerable effort in the last decade in defining the role of allogeneic and autologous bone marrow transplantation as consolidation treatment for first remission of acute myeloid leukemia in younger patients. These efforts have been able, more precisely, to quantitate the deg...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200003000-00002

    authors: Burnett AK,Kell J

    更新日期:2000-03-01 00:00:00

  • Anal carcinoma: histology, staging, epidemiology, treatment.

    abstract::Our understanding of the pathogenesis and management of squamous cell carcinoma of the anal canal has undergone profound change over the last 30 years. Epidemiologic studies have demonstrated that infection with human papillomavirus is most likely responsible for the majority of cases. Primary treatment with concomita...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200007000-00011

    authors: Ryan DP,Mayer RJ

    更新日期:2000-07-01 00:00:00

  • Reappraisal of eligibility criteria in cancer clinical trials.

    abstract:PURPOSE OF REVIEW:We aimed to summarize the recent reflections and collaborative initiatives pertaining to the definition of more appropriate eligibility criteria in cancer clinical trials. RECENT FINDINGS:There is an intrinsic tension between two opposite purposes when it comes to defining eligibility criteria: on th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000470

    authors: Penel N,Lebellec L,Vanseymortier M

    更新日期:2018-09-01 00:00:00

  • Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.

    abstract:PURPOSE OF REVIEW:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) constitute a diverse group of neoplasms arising from the diffuse neuroendocrine cell system. During the last 2 years a new classification system, the WHO 2010, has come into clinical practice together with Tumor Nodes Metastases (TNM) staging and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328353d7ba

    authors: Oberg K

    更新日期:2012-07-01 00:00:00

  • Surgical management of the lateral neck compartment for metastatic thyroid cancer.

    abstract:PURPOSE OF REVIEW:The lateral neck compartment is the second most frequent target region for metastatic papillary thyroid cancer (PTC) and medullary thyroid cancer (MTC). Lateral lymph node metastases are associated with locoregional recurrence and, when they involve either side of the neck, with mediastinal and distan...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328359ff1f

    authors: Dralle H,Machens A

    更新日期:2013-01-01 00:00:00

  • On mitochondrial metabolism in tumor biology.

    abstract:PURPOSE OF REVIEW:To provide examples of mitochondria-specific metabolic events that influence tumor cell biology, and of metabolism-related mitochondrial biomarkers and therapeutic targets in cancer cells. RECENT FINDINGS:Cancer cell mitochondria are rewired to optimally serve the cancer cell under various conditions...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000336

    authors: Shoshan M

    更新日期:2017-01-01 00:00:00

  • Management of noninfectious lung injury following hematopoietic cell transplantation.

    abstract:PURPOSE OF REVIEW:Over the past 20 years, tremendous strides have been made to decrease treatment-related morbidity and mortality following allogeneic transplant, including management of acute and chronic lung injury. Within this context, three distinct entities are recognized, idiopathic pneumonia syndrome (IPS), bron...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835dc8a5

    authors: Yanik G,Kitko C

    更新日期:2013-03-01 00:00:00

  • The transforming growth factor-beta signaling pathway in tumorigenesis.

    abstract::Transforming growth factor-beta is believed to play a dual role in carcinogenesis. Through its ability to inhibit cellular proliferation it suppresses tumor development in its early stages, but in the course of tumor progression malignant cells often acquire resistance to growth inhibition by transforming growth facto...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200101000-00014

    authors: Wieser R

    更新日期:2001-01-01 00:00:00

  • New active drugs in the treatment of lymphomas.

    abstract::Lymphomas include a vast number of pathologic conditions in which the search for new active drugs follows different routes. Hodgkin's disease and high-grade non-Hodgkin's lymphoma are very sensitive to chemotherapy, responding well to existing regimens; the inability to cure seems to be caused by acquired drug resista...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199409000-00006

    authors: Straneo M,Gianni L

    更新日期:1994-09-01 00:00:00

  • Treatment of AIDS-related lymphomas.

    abstract::Infection with HIV is associated with an increased risk of systemic and primary central nervous system non-Hodgkin's lymphoma. Patients with systemic non-Hodgkin's lymphoma usually present with high- or intermediate-grade histology and extranodal dissemination. Although the prognosis for such patients is poor, some pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Sparano JA

    更新日期:1995-09-01 00:00:00

  • Cutaneous manifestations of cancer.

    abstract::The appearance of skin lesions in patients with occult or obvious malignancy may be of extreme value in the detection and management of cancer because the skin is readily accessible to examination and biopsy. Examination of the skin of our patients can provide important insights into underlying malignant processes or ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199903000-00011

    authors: Sabir S,James WD,Schuchter LM

    更新日期:1999-03-01 00:00:00